Zuviplat
Brand Name: ZUVIPLAT®
Composition: Cisplatin Injection IP 50 mg/50 ml
Manufacturer: Zuvius Lifesciences (OncoAce Division)
Product Description
Medical Info
ZUVIPLAT® is a potent, prescription-only antineoplastic (chemotherapy) medication containing Cisplatin (50 mg in 50 ml). It belongs to the class of platinum-based alkylating agents and is supplied as a clear, sterile solution intended for single-dose intravenous infusion. Cisplatin is a cornerstone of chemotherapy, used to treat several types of advanced or metastatic cancers, including testicular, ovarian, and bladder cancers. It works by interfering with cancer cell DNA replication, ultimately leading to programmed cell death. Due to its significant toxicity, it requires administration by qualified oncological specialists under strict clinical supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
